This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Mesa Biotech, Inc.
Mesa Biotech, Inc., a leading player in the point-of-care diagnostics industry, is headquartered in the United States. Founded in 2015, the company has rapidly established itself as a pioneer in molecular testing, particularly with its innovative products designed for rapid and accurate infectious disease detection. Mesa Biotech's flagship product, the Accula™ system, stands out for its ease of use and speed, enabling healthcare providers to deliver timely results directly at the point of care. This unique approach not only enhances patient outcomes but also streamlines clinical workflows. With a strong market position, Mesa Biotech has garnered recognition for its commitment to advancing diagnostic technology, making significant strides in the healthcare landscape. The company continues to expand its operational reach, focusing on improving access to critical testing solutions across various regions.
DitchCarbon Score
How does Mesa Biotech, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mesa Biotech, Inc.'s score of 70 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mesa Biotech, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is part of a corporate family that includes Thermo Fisher Scientific Inc., from which it inherits climate-related commitments and performance metrics. As a merged entity, Mesa Biotech aligns its climate initiatives with those of Thermo Fisher Scientific Inc. This includes adherence to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements have not been disclosed for Mesa Biotech itself. The absence of direct emissions data suggests that Mesa Biotech is still in the process of establishing its own climate commitments or may rely on the broader corporate strategies of Thermo Fisher Scientific Inc. for guidance on sustainability practices. As the company continues to integrate its operations, it may adopt more defined climate goals in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 321,190,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 486,151,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mesa Biotech, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
